Prometheus Laboratories Announces Management Appointments
Prometheus Laboratories Inc., a specialty pharmaceutical company, today announced the recent appointments of Michael D. Allen as Vice President, Sales, Lee R. McCracken as Corporate Head of Business Development and Toni L. Wayne as Vice President, Human Resources.
"Our imperative is to continue the robust growth of our clinical diagnostics and pharmaceuticals business by gaining access to additional proprietary products and optimizing their commercial success," said Joseph M. Limber, President & Chief Executive Officer of Prometheus. "The addition of these proven business executives significantly enhances our senior management team and contributes to Prometheus' strong position for executing our business strategy."
Mr. Allen brings over twenty years of experience in the pharmaceutical/biotechnology industry with expertise in global sales, marketing and general management, and leading commercial operations in turn around and rapid growth environments. Mr. Allen was most recently Executive Vice President of Sales and Marketing at Ther-Rx Corp., a specialty pharmaceutical company and subsidiary of KV Pharmaceuticals, where he had primary responsibility for leading commercial operations. Prior to joining KV Pharmaceuticals, he was at Serono Inc. where most recently he was Executive Vice President, North American Reproductive Health Business Unit. In this capacity, Mr. Allen had commercial responsibility for six promoted brands and led the growth of the business to over $250 million in sales. Also at Serono, Mr. Allen held the position of General Manager, Serono Canada, as well as various sales management positions. Prior to his tenure at Serono, Mr. Allen held positions of increasing responsibility in sales training and sales management at Ortho Pharmaceutical, a Johnson & Johnson company.
Mr. McCracken's over twenty years of business experience spans the pharmaceutical/biotechnology industry, venture capital business, and information technology sector. Prior to joining Prometheus, Mr. McCracken was Senior Vice President Pharmaceutical Business Development of Diversa Corporation, where he was responsible for strategy, mergers and acquisitions, and corporate partnering. Mr. McCracken has also served in senior executive roles in privately financed start-ups to established public companies such as Allergan, CombiChem (merged into DuPont Pharma), and GenStar Therapeutics (merged into Corautus). As a venture capitalist with Union Venture and 3i Group plc, he invested in both early and later stage companies.
Ms. Wayne also brings twenty years of industry experience having served as Vice President, Human Resources at Baxter Healthcare's BioScience division and Elan Pharmaceutical's Biopharmaceutical division. In these positions, Ms. Wayne provided human resources leadership for both global research and development and commercial organizations. Prior to her positions with Baxter and Elan, Ms. Wayne served in varying positions of management responsibility in human resources, manufacturing, quality and project management at Hybritech Incorporated, which became a division of Eli Lilly. Ms. Wayne originally began her career in research with Scripps Clinic and Research Foundation.
return to CRP in the News >